| Literature DB >> 28821819 |
Chen Gong1, Zhiping Long1, Yanming Yu1, Lin Zhu1, Jingshen Tian1, Shuo Li1, Jing Li1, Hongyuan Yu1, Qiang Chi2, Daxun Piao3, Fan Wang4, Yashuang Zhao5, Binbin Cui6.
Abstract
CYP24A1 and CYP27B1 are critical genes determining 1α,25(OH)2D3 concentration and impacting on carcinogenesis. A case-control study including 528 colorectal cancer (CRC) patients and 605 cancer-free controls and a follow-up study with 317 cases were conducted in northeast China. Genotypes were tested by TaqMan Genotyping Assays. Individuals carrying the GG genotype of CYP27B1 G > T (rs10877012) exhibited decreased CRC risk compared with those with the TT genotype (ORadjusted (ORadj) = 0.57, 95% Confidence Interval (CI) = 0.38-0.84). Compared with the TT genotype, a significant association between the CC genotype of CYP27B1 C > T (rs4646536) and a reduced risk of CRC was observed (ORadj = 0.59, 95% CI = 0.40-0.88). We also observed significant combined effects of the two polymorphisms in CYP27B1 with dietary factors, including the intake of cereals, overnight meal, allium vegetables, pork, canned fruit, and braised fish, on CRC risk. These associations remained significant after Bonferroni correction for multiple comparisons. The Hazard Ration (HR) of patients with the AA genotype (CYP24A1 A > G, rs4809957) was 2.38 (95% CI = 1.30-4.37) when compared with the GG genotype. Thus, our findings suggested that two polymorphisms in CYP27B1 are associated with CRC susceptibility. CYP24A1 A > G (rs4809957) polymorphism may lead to a worse prognosis of CRC.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28821819 PMCID: PMC5562792 DOI: 10.1038/s41598-017-09356-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic characteristics of study subjects.
|
|
|
|
|
|---|---|---|---|
|
|
| ||
|
|
| ||
| <50 | 88 (16.67) | 152 (25.12) | |
| ≥50 and <60 | 161 (30.49) | 210 (34.71) | |
| ≥60 and <70 | 157 (29.74) | 152 (25.12) | |
| ≥70 | 122 (23.11) | 91 (15.04) | |
| Mean ± SD | 60.31 ± 11.30 | 57.14 ± 11.21 | |
|
| 0.685 | ||
| Male | 310 (58.71) | 348 (57.52) | |
| Female | 218 (41.29) | 257 (42.48) | |
|
|
| ||
| ≤18.5 | 40 (7.59) | 35 (5.86) | |
| >18.5 and ≤23 | 208 (39.47) | 189 (31.66) | |
| >23 and ≤30 | 266 (50.47) | 330 (55.28) | |
| >30 | 13 (2.47) | 43 (7.20) | |
| Mean ± SD | 23.26 ± 3.37 | 24.30 ± 4.21 | |
|
| 0.267 | ||
| Mental worker | 134 (25.97) | 175 (29.31) | |
| Physical worker | 97(18.80) | 121 (20.27) | |
| Mixed | 285 (55.23) | 301 (50.42) | |
|
| 0.102 | ||
| No | 418 (80.85) | 509 (84.55) | |
| Yes | 99 (19.15) | 93 (15.45) |
aMissing data: occupation, 4 cases; BMI, 1 case, 8 controls; family history of cancer, 11 cases, 3 controls.
bBMI, body mass index (weight/height2).
cOccupation: mental worker (white-collar worker) is the person who perform professional, managerial, or administrative work, such as civil servants, administrative management, scientific research, or education. Physical worker is the person whose job requires manual labor, such as farmer in our questionnaire.
Associations between the polymorphisms in CYP24A1, CYP27B1 and the risk of colorectal cancer.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| ||||||
| GG | 206 (39.31) | 230 (38.66) | 1.00 | |||
| AG | 260 (49.62) | 295 (49.58) | 0.98 (0.76–1.26) | 0.867 | 1.000 | |
| AA | 58 (11.07) | 70 (11.77) | 0.96 (0.64–1.44) | 0.844 | 1.000 | |
| Dominant model | 0.98 (0.76–1.25) | 0.840 | 1.000 | 1508.38 | ||
| Recessive model | 0.97 (0.67–1.42) | 0.884 | 1.000 | 1508.40 | ||
| Additive model | 0.98 (0.82–1.18) | 0.824 | 1.000 | 1508.38 | ||
|
| ||||||
| GG | 402 (77.76) | 467 (78.49) | 1.00 | |||
| AG | 109 (21.08) | 120 (20.17) | 1.01 (0.75–1.35) | 0.972 | 1.000 | |
| AA | 6 (1.16) | 8 (1.35) | 0.92 (0.31–2.72) | 0.885 | 1.000 | |
| Dominant model | 1.00 (0.75–1.34) | 0.998 | 1.000 | 1499.95 | ||
| Recessive model | 0.92 (0.31–2.71) | 0.883 | 1.000 | 1499.92 | ||
| Additive model | 0.97 (0.76–1.30) | 0.972 | 1.000 | 1499.94 | ||
|
| ||||||
| TT | 232 (47.44) | 230 (42.13) | 1.00 | |||
| GT | 206 (42.13) | 233 (42.67) | 0.86 (0.66–1.13) | 0.282 | 1.000 | |
| GG | 51 (10.43) | 83 (15.20) | 0.57 (0.38–0.84) |
|
| |
| Dominant model | 0.78 (0.61–1.00) | 0.053 | 0.212 | 1394.31 | ||
| Recessive model | 0.61 (0.42–0.88) |
|
| 1391.16 | ||
| Additive model | 0.78 (0.65–0.94) |
|
| 1390.30 | ||
|
| ||||||
| TT | 233 (48.04) | 229 (42.57) | 1.00 | |||
| CT | 200 (41.24) | 229 (42.57) | 0.84 (0.64–1.09) | 0.190 | 0.760 | |
| CC | 52 (10.72) | 80 (14.87) | 0.59 (0.40–0.88) |
|
| |
| Dominant model | 0.77 (0.60–0.99) |
| 0.120 | 1375.63 | ||
| Recessive model | 0.64 (0.44–0.94) |
| 0.092 | 1374.46 | ||
| Additive model | 0.78 (0.66–0.95) |
|
| 1373.10 | ||
aOR: odds ratio; CI: confidence interval. ORadj: adjusted by age, and BMI.
bmissing values: rs4809957, 14; rs2762934, 21; rs10877012, 98; rs4646536, 110.
P : P values after Bonferroni correction.
Subgroup analyses for the associations between rs10877012, rs4646536 in CYP27B1 and the risk of colorectal cancer.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| ≤ | ||||||
| Controls/cases | 148/119 | 152/105 | 45/28 | 148/119 | 148/102 | 44/28 |
| ORadj a (95% CI) | 1.00 | 0.87 (0.61–1.24) | 0.76 (0.45–1.29) | 1.00 | 0.85 (0.60–1.21) | 0.77 (0.45–1.31) |
|
| 0.443 | 0.312 | 0.363 | 0.333 | ||
|
| 1.000 | 1.000 | 1.000 | 1.000 | ||
|
| ||||||
| Controls/cases | 82/112 | 81/101 | 38/23 | 81/114 | 81/98 | 36/24 |
| ORadj (95% CI) | 1.00 | 0.85 (0.56–1.29) | 0.39 (0.21–0.71) | 1.00 | 0.82 (0.54–1.24) | 0.42 (0.23–0.78) |
|
| 0.446 |
| 0.344 |
| ||
|
| 1.000 |
| 1.000 |
| ||
|
| ||||||
|
| ||||||
| Controls/cases | 134/130 | 138/125 | 43/31 | 132/131 | 136/121 | 43/33 |
| ORadj (95% CI) | 1.00 | 0.96 (0.68–1.36) | 0.69 (0.41–1.17) | 1.00 | 0.90 (0.63–1.27) | 0.72 (0.42–1.20) |
|
| 0.809 | 0.172 | 0.534 | 0.207 | ||
|
| 1.000 | 0.688 | 1.000 | 0.828 | ||
|
| ||||||
| Controls/cases | 96/101 | 95/81 | 40/20 | 97/102 | 93/79 | 37/19 |
| ORadj (95% CI) | 1.00 | 0.71 (0.47–1.09) | 0.43 (0.23–0.79) | 1.00 | 0.74 (0.48–1.13) | 0.44 (0.23–0.84) |
|
| 0.113 |
| 0.161 |
| ||
|
| 0.452 |
| 0.644 |
| ||
|
| ||||||
|
| ||||||
| Controls/cases | 59/50 | 68/55 | 31/21 | 60/53 | 65/52 | 30/20 |
| ORadj (95% CI) | 1.00 | 0.94 (0.56–1.60) | 0.70 (0.35–1.39) | 1.00 | 0.85 (0.50–1.44) | 0.67 (0.34–1.34) |
|
| 0.830 | 0.311 | 0.542 | 0.254 | ||
|
| 1.000 | 1.000 | 1.000 | 1.000 | ||
|
| ||||||
| Controls/cases | 50/50 | 44/34 | 17/9 | 50/49 | 42/35 | 16/9 |
| ORadj (95% CI) | 1.00 | 0.72 (0.39–1.34) | 0.38 (0.15–1.00) | 1.00 | 0.82 (0.44–1.52) | 0.43 (0.17–1.13) |
|
| 0.304 | 0.049 | 0.530 | 0.087 | ||
|
| 1.000 | 0.196 | 1.000 | 0.348 | ||
|
| ||||||
| Controls/cases | 119/126 | 116/112 | 35/20 | 117/126 | 117/108 | 34/22 |
| ORadj (95% CI) | 1.00 | 0.91 (0.63–1.32) | 0.51 (0.27–0.94) | 1.00 | 0.83 (0.57–1.21) | 0.55 (0.30–1.01) |
|
| 0.611 | 0.030 | 0.338 | 0.054 | ||
|
| 1.000 | 0.120 | 1.000 | 0.216 | ||
|
| ||||||
|
| ||||||
| Controls/cases | 230/84 | 233/65 | 83/15 | 229/84 | 229/59 | 80/17 |
| ORadj (95% CI) | 1.00 | 0.72 (0.49–1.06) | 0.42 (0.23–0.78) | 1.00 | 0.66 (0.44–0.97) | 0.50 (0.28–0.91) |
|
| 0.093 |
| 0.036 | 0.022 | ||
|
| 0.372 |
| 0.144 | 0.088 | ||
|
| ||||||
| Controls/cases | 230/135 | 233/132 | 83/32 | 229/136 | 229/132 | 80/30 |
| ORadj (95% CI) | 1.00 | 0.95 (0.70–1.29) | 0.61 (0.38–0.97) | 1.00 | 0.94 (0.70–1.28) | 0.59 (0.37–0.95) |
|
| 0.743 | 0.037 | 0.713 | 0.028 | ||
|
| 1.000 | 0.148 | 1.000 | 0.112 | ||
Non-mental workers include physical workers and mixed workers.
Note: No significant associations were observed between rs4809957, rs2762934 in CYP24A1 and CRC risk in subgroup analyses and the results were not listed.
P *: P values after Bonferroni correction. aORadj: adjusted by age, and BMI.
Combined and interactive effects between polymorphisms in CYP24A1 and dietary factors in CRC.
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||
|
|
|
|
| |||||||
| Cereals (g/week) | ||||||||||
| | 1.00 | 1.01 (0.67–1.53) | 0.88 (0.53–1.48) | 0.640 | 1.00 | 1.17 (0.19–7.23) | 0.70 (0.07–7.04) | 0.763 | ||
| ≥50 | 0.45 (0.30–0.68) |
| 0.42 (0.33–0.55) | 0.35 (0.08–1.44) | ||||||
| Overnight meal (times/week) | ||||||||||
| >3 | 1.00 | 1.05 (0.70–1.56) | 1.09 (0.66–1.82) | 0.740 | 1.00 | — | — | — | ||
| ≤3 | 0.67 (0.45–1.00) | 0.65 (0.45–0.93) | 0.64 (0.50–0.82) | 0.97 (0.31–3.13) | ||||||
| Allium vegetable (time/week) | ||||||||||
| | 1.00 | 0.95 (0.59–1.52) | 1.05(0.60–1.82) | 0.876 | 1.00 | 0.69 (0.11–4.20) | 1.51 (0.16–14.33) | 0.721 | ||
| ≥1 | 0.73(0.47–1.25) | 0.72(0.48–1.09) | 0.75 (0.57–0.99) | 0.78 (0.20–3.01) | ||||||
| Pork (g/week) | ||||||||||
| ≥250 | 1.00 | 0.97 (0.67–1.42) | 1.10 (0.66–1.82) | 0.719 | 1.00 | 2.28 (0.43–12.12) | 8.85 (0.59–132.9) | 0.115 | ||
| | 0.66 (0.44–0.98) | 0.58 (0.40–0.84) | 0.62 (0.48–0.79) | 0.17 (0.02–1.44) | ||||||
| Milk (time/week) | ||||||||||
| ≤2 | 1.00 | 0.80 (0.58–1.12) | 1.68 (0.96–2.93) | 0.068 | 1.00 | 0.91 (0.26–3.24) | — | — | ||
| >2 | 0.59 (0.38–0.92) | 0.80 (0.54–1.17) | 0.84 (0.64–1.11) | — | ||||||
| Vegetable (g/day) | ||||||||||
| ≤250 | 1.00 | 0.92 (0.68–1.24) | 1.21 (0.71–2.05) | 0.462 | 1.00 | 0.75 (0.18–3.21) | 1.51 (0.17–13.45) | 0.714 | ||
| >250 | 1.07(0.72–1.62) | 1.20 (0.82–1.74) | 1.25 (0.96–1.63) | 1.42 (0.28–7.23) | ||||||
| Canned fruit | ||||||||||
| Yes | 1.00 | 0.59 (0.22–1.62) | 0.63 (0.22–1.77) | 0.378 | 1.00 | — | — | — | ||
| No | 0.39 (0.16–0.92) | 0.37 (0.16–0.87) | 0.50 (0.31–0.81) | 0.54 (0.16–1.79) | ||||||
| Braised fish (times/week) | ||||||||||
| ≥1 | 1.00 | 1.12 (0.71–1.77) | 1.26 (0.73–2.17) | 0.446 | 1.00 | 0.49 (0.04–5.53) | 0.42 (0.03–6.33) | 0.533 | ||
| | 0.64(0.42–1.00) | 0.57 (0.38–0.87) | 0.54 (0.41–0.70) | 0.63 (0.18–2.12) | ||||||
| Soybean (times/week) | ||||||||||
| >1 | 1.00 | 0.97 (0.73–1.29) | 1.02 (0.58–1.81) | 0.627 | 1.00 | 0.74 (0.21–2.69) | 0.44 (0.04–4.76) | 0.502 | ||
| ≤1 | 0.81 (0.52–1.26) | 0.77 (0.52–1.14) | 0.77 (0.58–1.02) | 1.29 (0.18–9.36) | ||||||
ORgd: ORgenetic&dietary, combined effects of polymorphisms and dietary factors. ORi: ORinteraction, interactive effects of polymorphisms and dietary factors.
Note, we analyzed the combined effects for nine dietary factors and four polymorphisms of CYP24A1 and CYP27B1, the P value after Bonferroni correction is 0.05/36 = 0.0014. We analyzed the interactive effects using logistic regression, the significant P value of interactive effect is 0.05.
*Bold values indicate significance after Bonferroni correction.
Combined and interactive effects between polymorphisms in CYP27B1 and dietary factors in CRC.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
|
|
|
|
| |||||
| Cereals (g/week) | ||||||||
| | 1.00 | 0.43 (0.23–0.79) | 1.76 (0.80–3.84) | 0.160 | 1.00 | 0.46 (0.25–0.85) | 1.77 (0.80–3.90) | 0.159 |
| ≥50 | 0.41 (0.319–0.55) |
| 0.40 (0.30–0.54) |
| ||||
| Overnight meal (times/week) | ||||||||
| >3 | 1.00 | 0.44 (0.22–0.85) | 0.60 (0.27–1.34) | 0.211 | 1.00 | 0.49 (0.24–0.97) | 0.63 (0.28–1.45) | 0.281 |
| ≤3 | 0.62 (0.47–0.81) |
| 0.64 (0.48–0.84) |
| ||||
| Allium vegetable (time/week) | ||||||||
| | 1.00 | 0.82 (0.42–1.60) | 0.62 (0.28–1.41) | 0.254 | 1.00 | 0.91 (0.45–1.83) | 0.60 (0.26–1.39) | 0.235 |
| ≥1 | 0.80 (0.59–1.08) |
| 0.78 (0.57–1.06) |
| ||||
| Pork (g/week) | ||||||||
| ≥250 | 1.00 | 0.68 (0.37–1.24) | 1.29 (0.59–2.82) | 0.531 | 1.00 | 0.63 (0.35–1.15) | 1.05 (0.48–2.29) | 0.910 |
| | 0.64 (0.49–0.85) |
| 0.64 (0.49–0.85) |
| ||||
| Milk (time/week) | ||||||||
| ≤2 | 1.00 | 0.57 (0.35–0.93) | 1.19 (0.51–2.82) | 0.685 | 1.00 | 0.58 (0.35–0.95) | 1.34 (0.57–3.17) | 0.501 |
| >2 | 0.80 (0.59–1.09) | 0.54 (0.27–1.08) | 0.78 (0.57–1.06) | 0.61 (0.30–1.21) | ||||
| Vegetable (g/day) | ||||||||
| ≤250 | 1.00 | 0.54 (0.34–0.85) | 1.51 (0.66–3.50) | 0.332 | 1.00 | 0.56 (0.36–0.89) | 1.58 (0.69–3.65) | 0.279 |
| >250 | 1.15 (0.86–1.54) | 0.94 (0.48–1.87) | 1.13 (0.84–1.52) | 1.01 (0.51–1.98) | ||||
| Canned fruit | ||||||||
| Yes | 1.00 | 0.23 (0.04–1.34) | 0.33 (0.05–2.07) | 0.237 | 1.00 | 0.40 (0.07–2.21) | 0.57 (0.10–3.29) | 0.527 |
| No | 0.48 (0.28–0.81) |
| 0.48 (0.28–0.82) |
| ||||
| Braised fish (times/week) | ||||||||
| ≥1 | 1.00 | 0.43 (0.22–0.86) | 0.63 (0.28–1.45) | 0.278 | 1.00 | 0.40 (0.20–0.80) | 0.51 (0.22–1.17) | 0.112 |
| | 0.50 (0.37 |
| 0.48 (0.36 |
| ||||
| Soybean (times/week) | ||||||||
| >1 | 1.00 | 0.62 (0.41 | 1.18 (0.44 | 0.740 | 1.00 | 0.66 (0.43 | 1.17 (0.43 | 0.755 |
| ≤1 | 0.81 (0.59 | 0.42 (0.18 | 0.82 (0.59 | 0.46 (0.19 | ||||
ORgd: ORgenetic&dietary, combined effects of polymorphisms and dietary factors. ORi: ORinteraction, interactive effects of polymorphisms and dietary factors.
Note, we analyzed the combined effects for nine dietary factors and four polymorphisms of CYP24A1 and CYP27B1, the P value after Bonferroni correction is 0.05/36 = 0.0014. We analyzed the interactive effects using logistic regression, the significant P value of interactive effect is 0.05.
*Bold values indicate significance after Bonferroni correction.
Associations between clinical characteristics, polymorphisms in CYP24A1, CYP27B1 and the prognosis of CRC.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
|
|
| |||
|
| 0.404 | 0.753 | ||
| Colon | 1 | 1 | ||
| Rectum | 1.24 (0.87 | 0.230 | 1.00 (0.65 | 0.986 |
| Cecum | 0.85 (0.30 | 0.754 | 0.67 (0.22 | 0.470 |
|
|
|
| ||
| Protrude type | 1 | 1 | ||
| Invasive and | 2.02 (1.44 |
| 1.57 (1.09 |
|
| ulcerative type | ||||
| Other type | 3.66 (1.93 |
| 3.83 (1.75 |
|
|
| 0.782 | 0.660 | ||
| Adenocarcinoma | 1 | 1 | ||
| Mucinous adenocarcinoma | 0.99 (0.53 | 0.972 | 0.81 (0.37 | 0.603 |
| Other type | 1.34 (0.59 | 0.485 | 1.37 (0.48 | 0.559 |
|
|
|
| ||
| I | 1 | 1 | ||
| II | 1.71 (0.81 | 0.163 | 1.93 (0.85 | 0.112 |
| III | 4.27 (2.05 |
| 8.87 (1.95 |
|
| IV | 16.47 (7.05 |
| 40.407 (7.80 |
|
|
|
| 0.691 | ||
| Low | 1 | 1 | ||
| Medium | 0.51 (0.34 |
| 0.76 (0.48 | 0.254 |
| High | 0.73 (0.25 | 0.555 | 0.76 (0.16 | 0.727 |
| Unknown | 0.80 (0.39 | 0.543 | 0.71 (0.26 | 0.506 |
|
|
| 0.438 | ||
| No | 1 | 1 | ||
| Yes | 3.09 (2.20 | 0.59 (0.16 | ||
|
| 0.896 | 0.206 | ||
| No | 1 | 1 | ||
| Yes | 1.02 (0.73 | 0.78 (0.54 | ||
|
|
|
| ||
| Yes | 1 | 1 | ||
| No | 1.46 (1.00 |
| 1.80 (1.13 |
|
| Undetermined | 1.93 (1.10 |
| 1.90 (1.02 |
|
|
|
|
| ||
| GG | 1 | 1 | ||
| AG | 0.99 (0.69 | 0.962 | 1.20 (0.79 | 0.399 |
| AA | 2.04 (1.25 |
| 2.38 (1.30 |
|
|
| 0.370 | 0.945 | ||
| GG | 1 | 1 | ||
| GA | 1.20 (0.81 | 1.02 (0.63 | ||
| AA | — | — | — | |
|
| 0.888 | 0.296 | ||
| TT | 1 | 1 | ||
| GT | 0.99 (0.69 | 0.940 | 0.58 (0.17 | 0.398 |
| GG | 0.87 (0.50 | 0.628 | 2.93 (0.41 | 0.285 |
|
| 0.795 | 0.226 | ||
| CC | 1 | 1 | ||
| CT | 1.05 (0.73 | 0.807 | 1.54 (0.45 | 0.497 |
| TT | 0.85 (0.48 | 0.585 | 0.24 (0.03 | 0.168 |
Hazard ratio (HR), adjusted by age and BMI.
Figure 1Kaplan-Meier curves of overall survival in CRC (colon and rectal cancer). for CYP24A1 rs480957 and CYP27B1 rs4646536 polymorphisms ((A). CYP24A1 rs480957 in CRC, (B) CYP24A1 rs480957 in colon cancer, (C) CYP24A1 rs480957 in rectal cancer, (D) CYP27B1 rs4646536 in colon cancer).